Christopher Hill

Christopher Hill

Chief Executive Officer at ADAPTIMMUNE THERAPEUTICS PLC
46 year
Finance
Health Technology
Commercial Services

Profile

Christopher James Hill is currently Director, Chief Executive & Financial Officer at Adaptimmune Therapeutics Plc since 2025.
Mr. Hill is also Director at Cjh Financial LLC and Connexin Therapeutics Ltd, and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Director at OXECO Ltd., CFO, Secretary & Executive Director at Abaco Capital Plc, Director at Oxford Pharmascience Ltd. from 2013 to 2020, Secretary, Director, Finance Director & Controller at Quoram Ltd. in 2013, Group Financial Controller at ORA Capital Partners Ltd., and Chief Financial & Operating Officer at Istesso Ltd. from 2021 to 2025.
Education includes an undergraduate degree from Leeds Beckett University, conferred in 2001.

Christopher Hill active positions

CompaniesPositionStart
ADAPTIMMUNE THERAPEUTICS PLC Chief Executive Officer 14/11/2025
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -

Former positions of Christopher Hill

CompaniesPositionEnd
Director of Finance/CFO 09/09/2025
Director/Board Member 31/12/2020
Director/Board Member 30/04/2020
QUORAM PLC Director of Finance/CFO -
Comptroller/Controller/Auditor -
See the detail of Christopher Hill's experience

Education of Christopher Hill

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Christopher Hill